ADMA ADMA Biologics Inc - Common Stock
$9,96
Prix · Aoû 19, 2026
Données fondamentales au Aoû 5, 2026
Fourchette 52 semaines
$7–$20
21% of range
Note des analystes
BUY
11 analysts
Objectif de cours
$17
+71% upside
P/E (TTM)
16.6
ROE
33.6%
Marge nette
28.8%
À propos de ADMA Biologics Inc - Common Stock Présentation de l'entreprise depuis Wikipedia
ADMA Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$9.96
Capitalisation Boursière
$2.37B
P/E (TTM)
16.6
BPA (TTM)
$0.60
Revenus (TTM)
$510M
Rendement div.
—
ROE
33.6%
Dette/Capitaux propres
0.2
Fourchette 52 semaines
$7 – $20
ADMA Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$510M
2023-12-31
→
2025-12-31
BPA
$0.60
2023-12-31
→
2025-12-31
Flux de trésorerie libre
$28M
2023-12-31
→
2025-12-31
Marges
28.8%
2023-12-31
→
2025-12-31
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
ADMA
Médiane des pairs
P/E (TTM)
16.6
55.4
P/S (TTM)
4.6
7.7
P/B
5.0
7.1
EV / EBITDA
11.8
—
Price / FCF (Cours / FCF)
85.1
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
ADMA
Médiane des pairs
Gross Margin (Marge Brute)
57.4%
71.7%
Operating Margin (Marge d'exploitation)
37.5%
—
Net Profit Margin (Marge nette)
28.8%
-2.0%
ROA
26.4%
-32.7%
ROE
33.6%
-37.9%
ROIC
28.0%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
ADMA
Médiane des pairs
Debt / Equity (Dette / Capitaux propres)
0.2
18.7
Current Ratio (Ratio de liquidité)
6.7
7.4
Quick Ratio (Ratio de liquidité réduite)
3.5
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
ADMA
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
19.6%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
49.0%
—
Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans)
64.6%
—
EPS YoY (BPA Année/Année)
-25.9%
—
Net Income YoY (Bénéfice net YoY)
-25.7%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
ADMA
Médiane des pairs
ADMA Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
11 analystes
- Achat fort 2 18,2%
- Achat 7 63,6%
- Conserver 2 18,2%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
5 analystes · 2026-08-17
Médiane
$17.00
← En dessous de tous les objectifs
$9.96
Bas
$12.00
Haut
$21.00
Objectif médian
$17.00
+70,8%
Objectif moyen
$17.00
+70,8%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
-0.01%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $0.16 | $0.18 | -0.02% |
| 31 mars 2026 | $0.19 | $0.20 | -0.01% |
| 31 décembre 2025 | $0.20 | $0.19 | 0.01% |
| 30 septembre 2025 | $0.15 | $0.15 | -0.00% |
| 30 juin 2025 | $0.14 | $0.14 | -0.00% |
| 31 mars 2025 | $0.11 | $0.16 | -0.05% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| ADMA | $4.34B | 30.4 | 19.6% | 28.8% | 33.6% | 57.4% |
| COAG | — | — | — | — | — | — |
| MLYS | $2.96B | -15.8 | — | — | -32.2% | — |
| KLRA | — | — | — | — | — | — |
| VERA | — | -10.9 | — | — | -55.9% | — |
| VCEL | $1.82B | 112.5 | 16.4% | 6.0% | 5.0% | 74.4% |
| GENB | — | — | — | — | — | — |
| PVLA | $1.30B | -28.2 | 65.3% | -1610.6% | -110.1% | — |
| AGIO | $1.59B | -3.8 | 48.0% | -764.0% | -32.2% | — |
| STOK | $1.87B | -264.5 | 404.5% | -3.7% | -2.0% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 18
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $510M | $426M | $258M | $154M | $81M | $42M | $29M | $17M | $23M | $11M | $7M | $6M | |
| Cost of Revenue | $217M | $207M | $169M | $119M | $80M | $61M | $40M | $42M | $29M | $2M | $4M | $4M | |
| Gross Profit | $293M | $220M | $89M | $35M | $1M | $-19M | · | $-25M | $-6M | $4M | $3M | $2M | |
| R&D Expense | $5M | $2M | $3M | $4M | $4M | $6M | $2M | $4M | $6M | $8M | $7M | $10M | |
| SG&A Expense | $92M | $74M | $59M | $52M | $43M | $35M | $26M | $23M | $19M | $8M | $7M | $5M | |
| Operating Expenses | $101M | $81M | $67M | $75M | $60M | $46M | $71M | $77M | $62M | $28M | $23M | $22M | |
| Operating Income | $191M | $139M | $22M | $-39M | $-58M | $-65M | $-41M | $-60M | $-39M | $-17M | $-16M | $-16M | |
| Interest Expense | · | · | $25M | $19M | $13M | $12M | $9M | $6M | $3M | $2M | $2M | $1M | |
| Interest Income | $2M | $2M | $2M | $45.0K | $35.0K | $288.1K | $800.8K | · | · | · | · | · | |
| Other Non-op | $-212.0K | $-193.0K | $-287.0K | $-635.0K | $-252.0K | $-128.5K | $-227.3K | $-127.1K | $-10.1K | $4.5K | $-2M | $-1M | |
| Pretax Income | $183M | $126M | $-28M | $-66M | · | · | · | · | · | $-20M | $-18M | $-17M | |
| Income Tax | $36M | $-72M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-551.7K | |
| Net Income | $147M | $198M | $-28M | $-66M | $-72M | $-76M | $-48M | $-66M | $-44M | $-20M | $-18M | $-17M | |
| EPS (Basic) | $0.62 | $0.85 | $-0.13 | $-0.33 | $-0.51 | $-0.88 | · | · | · | · | · | · | |
| EPS (Diluted) | $0.60 | $0.81 | $-0.13 | $-0.33 | $-0.51 | $-0.88 | · | · | · | · | · | · | |
| Shares (Basic) | 238,299,024 | 233,084,236 | 223,977,315 | 197,874,895 | 139,578,538 | 86,145,052 | · | · | · | · | · | · | |
| Shares (Diluted) | 244,904,640 | 243,342,466 | 223,977,315 | 197,874,895 | 139,578,538 | 86,145,052 | · | · | · | · | · | · | |
| EBITDA | $199M | $147M | $29M | $-33M | $-54M | $-62M | $-39M | $-58M | $-38M | $-17M | $-15M | $-16M |
Bilan 28
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $88M | $103M | $51M | $87M | $51M | $56M | $27M | $27M | $43M | $10M | $10M | $17M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $0 | $5M | $6M | $5M | |
| Receivables | $158M | $50M | $27M | $16M | $29M | $13M | $3M | $1M | $4M | $1M | $924.5K | $384.0K | |
| Inventory | $206M | $170M | $173M | $163M | $125M | $82M | $53M | $19M | $13M | $5M | $3M | $2M | |
| Prepaid Expense | $7M | $8M | $5M | $5M | $4M | $3M | $3M | $2M | $1M | $313.9K | $111.0K | $143.6K | |
| Current Assets | $467M | $331M | $257M | $270M | $209M | $154M | $86M | $45M | $62M | $22M | $21M | $24M | |
| PP&E (Net) | $65M | $55M | $54M | $58M | $51M | $42M | $32M | $30M | $30M | $2M | $2M | $3M | |
| PP&E (Gross) | $103M | $88M | $81M | $78M | $64M | $50M | $37M | $34M | $32M | $4M | $4M | $4M | |
| Accum. Depreciation | $38M | $34M | $27M | $19M | $13M | $9M | $6M | $3M | $1M | $2M | $2M | $1M | |
| Goodwill | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $0 | · | · | |
| Intangibles | $632.0K | $460.0K | $499.0K | $1M | $2M | $2M | $3M | $4M | $5M | $0 | · | · | |
| Total Assets | $624M | $489M | $329M | $348M | $276M | $208M | $127M | $89M | $108M | $24M | $24M | $27M | |
| Accounts Payable | $23M | $20M | $16M | $13M | $12M | $11M | $9M | $6M | $6M | $3M | $2M | $2M | |
| Accrued Liabilities | · | · | · | · | · | $8M | $4M | $4M | $3M | $2M | $2M | $2M | |
| Short-term Debt | · | · | · | · | · | · | · | $0 | $0 | $6M | $0 | · | |
| Current Liabilities | $70M | $56M | $50M | $39M | $30M | $20M | $14M | $10M | $9M | $11M | $4M | $4M | |
| Capital Leases | $7M | $9M | $10M | $11M | $7M | $4M | $1M | $119.1K | $0 | $19.7K | $36.3K | $51.4K | |
| Other Non-current Liabilities | $0 | $360.0K | $419.0K | $350.0K | $397.4K | $54.9K | $106.6K | $260.7K | $106.0K | $117.8K | $1M | $132.5K | |
| Total Liabilities | $147M | $140M | $194M | $196M | $135M | $119M | $101M | $69M | $68M | $28M | $23M | $21M | |
| Long-term Debt | $72M | $72M | · | · | · | · | $0 | $3M | $3M | $2M | · | · | |
| Total Debt | $72M | · | · | · | · | · | · | $0 | $0 | $6M | · | · | |
| Common Stock | $24.0K | $24.0K | $23.0K | $22.0K | $19.6K | $10.5K | $5.9K | $4.6K | $3.7K | $1.3K | $1.1K | $929 | |
| Paid-in Capital | $671M | $658M | $641M | $630M | $553M | $429M | $291M | $236M | $191M | $102M | $88M | $75M | |
| Retained Earnings | $-162M | $-309M | $-506M | $-478M | $-412M | $-340M | $-265M | $-216M | $-151M | $-107M | $-87M | $-69M | |
| Treasury Stock | $32M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $477M | $349M | $135M | $152M | $141M | $88M | $26M | $20M | $40M | $-4M | $821.0K | $6M | |
| Liabilities + Equity | $624M | $489M | $329M | $348M | $276M | $208M | $127M | $89M | $108M | $24M | $24M | $27M | |
| Shares Outstanding | 237,874,496 | 236,620,545 | 226,063,032 | 221,816,930 | 195,813,817 | 104,902,888 | 59,318,355 | 46,353,068 | 36,725,499 | 12,886,741 | 10,713,087 | 9,291,823 |
Flux de trésorerie 18
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $8M | $8M | $8M | $6M | $5M | $3M | $2M | $3M | $2M | $400.0K | $469.8K | $247.9K | |
| Stock-based Comp | $20M | $14M | $6M | $5M | $3M | $3M | $3M | $2M | $2M | $1M | $2M | $1M | |
| Deferred Tax | $11M | $-84M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $144.0K | $388.0K | $724.0K | $715.0K | $715.0K | $715.4K | $844.9K | $844.9K | $1M | $0 | · | · | |
| Other Non-cash | $-136M | $-16M | $23M | $-5M | $-49M | $-32M | $-33M | $-2M | $3M | $-473.5K | $370.7K | $611.9K | |
| Operating Cash Flow | $50M | $119M | $9M | $-60M | $-112M | $-102M | $-76M | $-63M | $-37M | $-18M | $-15M | $-15M | |
| CapEx | $23M | $8M | $5M | $14M | $14M | $13M | $4M | $2M | $3M | $73.4K | $26.1K | $2M | |
| Investing Cash Flow | $-22M | $-9M | $-5M | $-14M | $-14M | $-13M | $-4M | $-2M | $15M | $904.6K | $-2M | $-4M | |
| Debt Issued | · | · | · | · | · | $28M | $72M | $0 | $30M | $4M | · | · | |
| Net Debt Issued | · | · | · | · | · | $14M | $72M | $0 | $30M | · | · | · | |
| Stock Issued | · | $0 | $0 | $65M | $121M | $131M | $48M | $43M | $39M | $13M | $10M | $0 | |
| Stock Repurchased | $32M | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $-32M | $0 | $0 | $65M | $121M | $131M | $48M | $43M | $39M | $14M | $10M | $0 | |
| Financing Cash Flow | $-44M | $-58M | $-39M | $109M | $121M | $144M | $80M | $43M | $61M | $17M | $10M | $10M | |
| Net Change in Cash | $-16M | $52M | $-35M | $35M | $-5M | $29M | $-2.7K | $-22M | $39M | $-526.1K | $-7M | $-9M | |
| Taxes Paid | $20M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $28M | $110M | $4M | $-73M | $-126M | $-115M | $-80M | $-65M | $-40M | $-18M | $-15M | $-17M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-21M | $-17M | $-18M |
Rentabilité 8
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 57.4% | 51.5% | 34.4% | 22.9% | 1.5% | · | · | -148.4% | -28.1% | 40.3% | 39.9% | 36.7% | |
| Operating Margin | 37.5% | 32.6% | 8.4% | -25.6% | -72.1% | -153.8% | -141.1% | -354.9% | -172.7% | -162.6% | -216.1% | -270.8% | |
| Net Margin | 28.8% | 46.4% | -10.9% | -42.8% | -88.5% | -179.4% | -164.5% | -387.1% | -192.3% | -183.1% | -250.4% | -284.2% | |
| Pretax Margin | 35.8% | 29.5% | · | · | · | · | · | · | · | -183.1% | -250.4% | -293.6% | |
| EBITDA Margin | 39.1% | 34.4% | 11.3% | -21.4% | -66.2% | -146.2% | -133.0% | -339.6% | -166.1% | -158.1% | -209.6% | -266.6% | |
| ROA | 26.4% | 45.0% | -8.3% | -20.3% | -27.8% | -38.1% | -47.0% | -67.3% | -66.5% | -82.3% | -70.8% | -56.8% | |
| ROE | 33.6% | 68.1% | -19.7% | -52.2% | -58.7% | -94.9% | -155.0% | -230.8% | -243.9% | 1073.4% | -526.2% | -153.5% | |
| ROIC | 28.0% | 62.6% | · | · | · | · | · | · | · | -1047.9% | -1889.7% | -258.1% |
Liquidité et Solvabilité 5
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.7 | 6.0 | 5.2 | 6.9 | 6.9 | 7.7 | 6.1 | 4.6 | 6.7 | 1.9 | 5.0 | 5.7 | |
| Quick Ratio | 3.5 | 2.8 | 1.6 | 2.6 | 2.6 | 3.5 | 2.2 | 2.5 | 5.0 | 1.5 | 4.2 | 5.3 | |
| Debt / Equity | 0.2 | · | · | · | · | · | · | 0.0 | 0.0 | -1.4 | · | · | |
| LT Debt / Equity | 0.1 | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | 0.9 | -2.0 | -4.5 | -5.4 | -4.6 | -10.9 | -12.0 | -7.7 | -8.4 | -12.5 |
Efficacité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 1.0 | 0.8 | 0.5 | 0.3 | 0.2 | 0.3 | 0.2 | 0.3 | 0.4 | 0.3 | 0.2 | |
| Inventory Turnover | 1.2 | 1.2 | 1.0 | 0.8 | 0.8 | 0.9 | 1.1 | 2.7 | 0.3 | 1.5 | 1.7 | 2.8 | |
| Receivables Turnover | 4.9 | 11.0 | 12.0 | 7.0 | 3.9 | 5.1 | 12.1 | 6.4 | 9.3 | 11.0 | 11.0 | 13.6 |
Taux de croissance 5
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 19.6% | 65.1% | 67.6% | 90.4% | 91.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 49.0% | 74.0% | 82.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 64.6% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -25.9% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -25.7% | · | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM) 14
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $510M | $426M | $258M | $154M | $81M | $42M | $29M | $17M | $23M | $11M | $7M | $6M | |
| Net Income TTM | $147M | $198M | $-28M | $-66M | $-72M | $-76M | $-48M | $-66M | $-44M | $-20M | $-18M | $-17M | |
| Market Cap | $4.34B | $4.06B | $1.02B | $861M | $276M | $205M | $237M | $111M | $118M | $66M | $86M | $104M | |
| Enterprise Value | $4.32B | · | · | · | · | · | · | $88M | $75M | $57M | · | · | |
| P/E | 30.4 | 21.2 | -34.8 | -11.8 | -2.8 | -2.2 | · | · | · | · | · | · | |
| P/S | 8.5 | 9.5 | 4.0 | 5.6 | 3.4 | 4.8 | 8.1 | 6.5 | 5.2 | 6.2 | 12.0 | 17.5 | |
| P/B | 9.1 | 11.6 | 7.6 | 5.7 | 2.0 | 2.3 | 9.1 | 5.6 | 2.9 | -14.8 | 105.3 | 17.3 | |
| P / Tangible Book | 9.2 | 11.8 | 7.8 | 5.8 | 2.0 | 2.5 | · | · | · | · | · | · | |
| P / Cash Flow | 86.1 | 34.2 | 116.1 | -14.5 | -2.5 | -2.0 | -3.1 | -1.8 | -3.2 | -3.6 | -5.6 | -7.1 | |
| P / FCF | 156.0 | 36.7 | 253.6 | -11.7 | -2.2 | -1.8 | -3.0 | -1.7 | -3.0 | -3.6 | -5.6 | -6.1 | |
| EV / EBITDA | 21.7 | · | · | · | · | · | · | -1.5 | -2.0 | -3.4 | · | · | |
| EV / FCF | 155.4 | · | · | · | · | · | · | -1.4 | -1.9 | -3.1 | · | · | |
| EV / Revenue | 8.5 | · | · | · | · | · | · | 5.2 | 3.3 | 5.3 | · | · | |
| Earnings Yield | 3.3% | 4.7% | -2.9% | -8.5% | -36.2% | -45.1% | · | · | · | · | · | · |
Compte de résultat 18
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $124M | $114M | $139M | $134M | $122M | $115M | $118M | $120M | $107M | $82M | $74M | $67M | $60M | $57M | $50M | $41M | |
| Cost of Revenue | $38M | $34M | $50M | $59M | $55M | $54M | $54M | $60M | $50M | $43M | $43M | $43M | $43M | $40M | $36M | $31M | |
| Gross Profit | $86M | $81M | $89M | $76M | $67M | $61M | $63M | $60M | $57M | $39M | $31M | $25M | $17M | $17M | $14M | $10M | |
| R&D Expense | $6M | $3M | $1M | $2M | $1M | $826.0K | $391.0K | $412.0K | $560.0K | $450.0K | $446.0K | $596.0K | $1M | $855.0K | $1M | $1M | |
| SG&A Expense | $27M | $27M | $24M | $22M | $22M | $24M | $23M | $19M | $17M | $16M | $16M | $15M | $14M | $15M | $14M | $13M | |
| Operating Expenses | $34M | $22M | $26M | $25M | $24M | $26M | $25M | $20M | $18M | $17M | $17M | $16M | $17M | $17M | $20M | $19M | |
| Operating Income | $52M | $58M | $63M | $51M | $43M | $35M | $38M | $40M | $39M | $22M | $14M | $9M | $-473.0K | $-813.0K | $-6M | $-9M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $4M | · | $6M | $6M | $6M | · | $6M | |
| Interest Income | · | · | $487.0K | $376.0K | $400.0K | $608.0K | $598.0K | $666.0K | $449.0K | $384.0K | $614.0K | $423.0K | $414.0K | $166.0K | $2.4K | $7.2K | |
| Other Non-op | $-22.0K | $-140.0K | $-19.0K | $-21.0K | $-108.0K | $-64.0K | $-86.0K | $-56.0K | $-16.0K | $-35.0K | $-102.0K | $-145.0K | $-13.0K | $-27.0K | $-439.1K | $-9.6K | |
| Pretax Income | $50M | $57M | $62M | $48M | $40M | $33M | $35M | $37M | $36M | $18M | $-18M | $3M | $-6M | $-7M | · | · | |
| Income Tax | $12M | $12M | $12M | $11M | $6M | $7M | $-77M | $840.0K | $4M | $595.0K | $0 | $0 | $0 | $0 | · | · | |
| Net Income | $38M | $45M | $49M | $36M | $34M | $27M | $112M | $36M | $32M | $18M | $-18M | $3M | $-6M | $-7M | $-12M | $-15M | |
| EPS (Basic) | $0.17 | $0.19 | $0.22 | $0.15 | $0.14 | $0.11 | $0.48 | $0.15 | $0.14 | $0.08 | $-0.08 | $0.01 | $-0.03 | $-0.03 | $-0.05 | $-0.08 | |
| EPS (Diluted) | $0.16 | $0.19 | $0.20 | $0.15 | $0.14 | $0.11 | $0.45 | $0.15 | $0.13 | $0.08 | $-0.08 | $0.01 | $-0.03 | $-0.03 | $-0.05 | $-0.08 | |
| Shares (Basic) | 228,232,503 | 236,072,751 | -479,570,145 | 238,602,978 | 241,490,715 | 237,775,476 | -462,779,632 | 234,571,376 | 232,417,645 | 228,874,847 | -445,904,808 | 225,276,980 | 222,683,393 | 221,921,750 | -390,734,157 | 196,383,935 | |
| Shares (Diluted) | 230,337,048 | 239,955,762 | -493,044,433 | 244,664,263 | 248,608,460 | 244,676,350 | -480,043,045 | 244,804,065 | 242,167,072 | 236,414,374 | -454,389,090 | 233,761,262 | 222,683,393 | 221,921,750 | -390,734,157 | 196,383,935 | |
| EBITDA | $54M | $60M | · | $53M | $45M | $37M | · | $42M | $41M | $24M | · | $11M | $1M | $1M | · | $-8M |
Bilan 25
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $136M | $138M | $88M | $61M | $90M | $72M | $103M | $87M | $88M | $45M | · | $74M | $63M | $69M | · | $35M | |
| Receivables | $138M | $136M | $158M | $138M | $110M | $99M | $50M | $50M | $30M | $50M | · | $31M | $37M | $27M | · | $21M | |
| Inventory | $239M | $222M | $206M | $197M | $191M | $172M | $170M | $172M | $180M | $178M | · | $163M | $162M | $164M | · | $163M | |
| Prepaid Expense | $15M | $15M | $7M | $7M | $8M | $9M | $8M | $10M | $6M | $4M | · | $5M | $5M | $4M | · | $5M | |
| Current Assets | $528M | $511M | $467M | $403M | $400M | $352M | $331M | $318M | $304M | $276M | · | $274M | $266M | $264M | · | $224M | |
| PP&E (Net) | $67M | $65M | $65M | $70M | $58M | $58M | $55M | $54M | $54M | $55M | · | $55M | $56M | $57M | · | $57M | |
| PP&E (Gross) | $108M | $105M | $103M | · | $95M | $93M | $88M | $86M | $85M | $84M | · | $80M | $80M | $79M | · | $75M | |
| Accum. Depreciation | $42M | $40M | $38M | · | $38M | $35M | $34M | $32M | $31M | $29M | · | $25M | $23M | $21M | · | $18M | |
| Goodwill | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | · | $4M | $4M | $4M | · | $4M | |
| Intangibles | $575.0K | $630.0K | $632.0K | $491.0K | $527.0K | $452.0K | $460.0K | $485.0K | $479.0K | $321.0K | · | $476.9K | $655.7K | $834.6K | · | $1M | |
| Total Assets | $684M | $665M | $624M | $569M | $558M | $511M | $489M | $391M | $376M | $351M | $329M | $349M | $343M | $341M | $348M | $301M | |
| Accounts Payable | $32M | $21M | $23M | $24M | $30M | $21M | $20M | $16M | $14M | $17M | · | $11M | $12M | $13M | · | $25M | |
| Current Liabilities | $76M | $74M | $70M | $56M | $75M | $53M | $56M | $45M | $44M | $53M | · | $42M | $42M | $37M | · | $44M | |
| Capital Leases | $6M | $6M | $7M | $9M | $9M | $8M | $9M | $9M | $9M | $9M | · | $10M | $10M | $10M | · | $11M | |
| Other Non-current Liabilities | · | · | $0 | $90.0K | $2.0K | $2.0K | $360.0K | $375.0K | $390.0K | $405.0K | · | $434.6K | $449.5K | $338.7K | · | $362.2K | |
| Total Liabilities | $276M | $275M | $147M | $138M | $160M | $137M | $140M | $159M | $188M | $197M | · | $198M | $196M | $195M | · | $200M | |
| Long-term Debt | $197M | $197M | $72M | $72M | · | · | $72M | · | · | · | · | · | · | · | · | · | |
| Total Debt | $197M | $197M | · | $72M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $24.0K | $24.0K | $24.0K | $24.0K | $24.0K | $24.0K | $24.0K | $24.0K | $23.0K | $23.0K | · | $22.6K | $22.5K | $22.2K | · | $19.7K | |
| Paid-in Capital | $675M | $650M | $671M | $665M | $661M | $655M | $658M | $652M | $645M | $642M | · | $640M | $638M | $630M | · | $566M | |
| Retained Earnings | $-79M | $-116M | $-162M | $-211M | $-247M | $-282M | $-309M | $-420M | $-456M | $-488M | · | $-489M | $-491M | $-485M | · | $-466M | |
| Treasury Stock | $188M | $143M | $32M | $23M | $15M | · | $0 | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $408M | $390M | $477M | $431M | $398M | $373M | $349M | $232M | $188M | $154M | $135M | $151M | $147M | $146M | $152M | $100M | |
| Liabilities + Equity | $684M | $665M | $624M | $569M | $558M | $511M | $489M | $391M | $376M | $351M | · | $349M | $343M | $341M | · | $301M | |
| Shares Outstanding | 225,355,228 | 232,288,977 | 237,874,496 | 238,332,393 | 238,567,308 | 238,532,252 | 236,620,545 | 236,378,607 | 233,026,736 | 231,769,765 | · | 225,958,084 | 224,526,748 | 222,262,588 | · | 196,776,871 |
Flux de trésorerie 15
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Stock-based Comp | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | |
| Deferred Tax | $3.0K | $3M | $1M | $5M | $2M | $3M | $-84M | $0 | $0 | $0 | · | · | · | · | · | · | |
| Amort. of Intangibles | $55.0K | $55.0K | $49.0K | $38.0K | $32.0K | $25.0K | $25.0K | $28.0K | $142.0K | $193.0K | $187.0K | $179.0K | $179.0K | $179.0K | $178.5K | $178.8K | |
| Other Non-cash | · | $2M | · | · | · | $-57M | · | · | · | $-24M | · | · | · | $-11M | · | · | |
| Operating Cash Flow | $30M | $58M | $36M | $13M | $21M | $-20M | $50M | $25M | $46M | $-2M | $18M | $12M | $-6M | $-15M | $-7M | $-13M | |
| CapEx | $2M | $3M | $1M | $14M | $2M | $5M | $3M | $1M | $2M | $2M | $1M | $756.8K | $872.4K | $2M | $4M | $3M | |
| Investing Cash Flow | $-2M | $2M | $-276.0K | $-14M | $-3M | $-5M | $-3M | $-1M | $-2M | $-2M | $-1M | $-756.8K | $-872.4K | $-2M | $-4M | $-3M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $65M | $0 | |
| Stock Repurchased | $25M | $130M | $9M | $23M | $0 | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $-130M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-29M | $-10M | $-9M | $-28M | $48.0K | $-7M | $-31M | $-25M | $-362.0K | $-1M | $-39M | $416.4K | $240.5K | $-650.0K | $63M | $-843.8K | |
| Net Change in Cash | $-2M | $51M | $26M | $-29M | $19M | $-32M | $16M | $-2M | $43M | $-6M | $-23M | $12M | $-7M | $-17M | $52M | $-18M | |
| Free Cash Flow | · | $56M | · | · | · | $-24M | · | · | · | $-5M | · | · | · | $-17M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-8M | · | · | · | · | · | · |
Rentabilité 8
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.4% | 70.5% | · | 56.3% | 55.1% | 53.2% | · | 49.8% | 53.6% | 47.8% | · | 36.6% | 27.8% | 29.0% | · | 23.5% | |
| Operating Margin | 42.2% | 50.9% | · | 38.0% | 35.1% | 30.4% | · | 33.1% | 36.6% | 26.7% | · | 12.9% | -0.79% | -1.4% | · | -22.7% | |
| Net Margin | 30.4% | 39.6% | · | 27.1% | 28.1% | 23.4% | · | 30.0% | 29.9% | 21.8% | · | 3.8% | -10.6% | -11.9% | · | -36.3% | |
| Pretax Margin | 40.4% | 49.9% | · | 35.4% | 32.9% | 29.1% | · | 30.7% | 33.5% | 22.5% | · | · | · | · | · | · | |
| EBITDA Margin | 43.5% | 52.5% | · | 39.5% | 36.7% | 32.0% | · | 34.7% | 38.3% | 29.0% | · | 15.7% | 2.4% | 1.9% | · | -18.5% | |
| ROA | 6.1% | 7.7% | · | 7.6% | 7.3% | 6.2% | · | 9.7% | 8.9% | 5.1% | · | 0.79% | -2.0% | -2.1% | · | -5.5% | |
| ROE | 9.4% | 11.9% | · | 11.0% | 11.7% | 10.2% | · | 18.7% | 19.1% | 11.9% | · | 2.0% | -4.9% | -5.0% | · | -14.7% | |
| ROIC | 6.5% | 7.9% | · | 7.8% | 9.2% | 7.5% | · | 16.7% | 18.6% | 13.7% | · | · | · | · | · | · |
Liquidité et Solvabilité 5
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.0 | 7.0 | · | 7.1 | 5.3 | 6.6 | · | 7.1 | 6.9 | 5.2 | · | 6.5 | 6.3 | 7.2 | · | 5.0 | |
| Quick Ratio | 3.6 | 3.7 | · | 3.5 | 2.7 | 3.2 | · | 3.0 | 2.7 | 1.8 | · | 2.5 | 2.4 | 2.6 | · | 1.3 | |
| Debt / Equity | 0.5 | 0.5 | · | 0.2 | · | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.5 | 0.5 | · | 0.2 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 5.8 | · | 1.4 | -0.1 | -0.1 | · | -1.7 |
Efficacité 3
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.2 | |
| Receivables Turnover | 1.0 | 1.0 | · | 1.4 | 1.7 | 1.5 | · | 2.9 | 3.2 | 2.2 | · | 2.6 | 2.2 | 2.2 | · | 2.0 |
Valorisation (TTM) 14
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $495M | $486M | · | $491M | $464M | $424M | · | $376M | $316M | $266M | · | $225M | $192M | $161M | · | $125M | |
| Net Income TTM | $154M | $143M | · | $133M | $129M | $113M | · | $88M | $46M | $7M | · | $-25M | $-42M | $-60M | · | $-71M | |
| Market Cap | $1.89B | $2.09B | · | $3.49B | $4.34B | $4.73B | · | $4.73B | $2.61B | $1.53B | · | $809M | $829M | $736M | · | $478M | |
| Enterprise Value | $1.95B | $2.15B | · | $3.50B | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | 13.1 | 15.3 | · | 26.7 | 34.4 | 42.2 | · | 54.0 | 58.8 | 220.0 | · | -27.5 | -17.6 | -10.7 | · | -5.9 | |
| P/S | 3.8 | 4.3 | · | 7.1 | 9.4 | 11.2 | · | 12.6 | 8.2 | 5.7 | · | 3.6 | 4.3 | 4.6 | · | 3.8 | |
| P/B | 4.6 | 5.4 | · | 8.1 | 10.9 | 12.7 | · | 20.4 | 13.8 | 10.0 | · | 5.3 | 5.6 | 5.1 | · | 4.8 | |
| P / Tangible Book | 4.7 | 5.4 | · | 8.2 | 11.0 | 12.8 | · | 20.7 | 14.1 | 10.2 | · | 5.5 | 5.8 | 5.2 | · | 5.0 | |
| P / Cash Flow | · | 35.9 | · | · | · | -240.5 | · | · | · | -689.7 | · | · | · | -50.0 | · | · | |
| P / FCF | · | 37.6 | · | · | · | -194.1 | · | · | · | -335.1 | · | · | · | -44.1 | · | · | |
| EV / EBITDA | 36.0 | 35.8 | · | 66.1 | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / FCF | · | 38.6 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 3.9 | 4.4 | · | 7.1 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | 7.6% | 6.6% | · | 3.8% | 2.9% | 2.4% | · | 1.8% | 1.7% | 0.45% | · | -3.6% | -5.7% | -9.4% | · | -16.9% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| Revenu | $510M | — | — | $426M | — |
| Marge Brute % | 57.4% | — | — | 51.5% | — |
| Marge d'exploitation % | 37.5% | — | — | 32.6% | — |
| Résultat net | $147M | — | — | $198M | — |
| BPA dilué | $0.60 | — | — | $0.81 | — |
Bilan
| 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| Dette / Capitaux propres | 0.2 | — | — | — | — |
| Ratio de liquidité | 6.7 | — | — | 6.0 | — |
| Ratio de liquidité réduite | 3.5 | — | — | 2.8 | — |
Flux de trésorerie
| 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $28M | — | — | $110M | — |
Dernières actualités Actualités récentes mentionnant cette entreprise
- ADMA Biologics (ADMA) reçoit une extension d'étiquette de la FDA pour ASCENIV
- Voici ce que les analystes pensent d'ADMA Biologics (ADMA)
- Mizuho réduit l'objectif de cours d'ADMA Biologics Inc. (ADMA) à 24 $ contre 30 $
- ADMA Biologics (ADMA) annonce un programme de retour de capital de 200 millions de dollars, y compris un accord ASR de 125 millions de dollars.
Signaux de trading Signaux d'achat/vente récents avec prix d'entrée et ratio risque/récompense
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 364 déclarants · $1.2B total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 59 (-10 vs T. préc.) | 81 (+19 vs T. préc.) | 95 (-39 vs T. préc.) | 136 (+25 vs T. préc.) | +18.6M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| STATE STREET CORP | $143 261 104 | 17 116 022 | 11,67% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $84 568 881 | 10 103 809 | 6,89% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $84 440 661 | 10 088 490 | 6,88% | Actions |
| Rubric Capital Management LP | $78 170 895 | 9 339 414 | 6,37% | Actions |
| Capital Research Global Investors | $73 290 850 | 8 756 374 | 5,97% | Actions |
| FIRST TRUST ADVISORS LP | $65 272 197 | 7 798 351 | 5,32% | Actions |
| Caligan Partners LP | $47 918 309 | 5 725 007 | 3,90% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $43 542 717 | 5 201 126 | 3,55% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $28 505 265 | 3 405 647 | 2,32% | Actions |
| B Group, Inc. | $27 307 477 | 3 262 542 | 2,22% | Actions |
| Nuveen Asset Management, LLC | $22 724 385 | 1 325 037 | 1,85% | Actions |
| GOLDMAN SACHS GROUP INC | $21 445 388 | 2 562 173 | 1,75% | Actions |
| Nantahala Capital Management, LLC | $19 753 141 | 2 359 993 | 1,61% | Actions |
| D. E. Shaw & Co., Inc. | $19 393 708 | 2 317 050 | 1,58% | Actions |
| Ranger Investment Management, L.P. | $17 706 040 | 2 115 417 | 1,44% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $17 515 012 | 2 092 594 | 1,43% | Actions |
| TWO SIGMA INVESTMENTS, LP | $16 906 454 | 2 019 887 | 1,38% | Actions |
| KENNEDY CAPITAL MANAGEMENT LLC | $14 690 622 | 1 755 152 | 1,20% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $13 849 111 | 1 654 613 | 1,13% | Actions |
| Fundsmith LLP | $13 806 256 | 1 649 493 | 1,12% | Actions |
| Mesirow Institutional Investment Management, Inc. | $13 419 035 | 782 451 | 1,09% | Actions |
| Life Cycle Investment Partners Ltd | $12 747 351 | 1 522 981 | 1,04% | Actions |
| BANK OF AMERICA CORP /DE/ | $12 489 672 | 1 492 195 | 1,02% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $12 172 449 | 1 454 295 | 0,99% | Actions |
| CITADEL ADVISORS LLC | $11 467 494 | 1 370 071 | 0,93% | Actions |
| PRINCIPAL FINANCIAL GROUP INC | $11 400 467 | 1 362 063 | 0,93% | Actions |
| Clearline Capital LP | $11 171 648 | 1 334 725 | 0,91% | Actions |
| Qube Research & Technologies Ltd | $11 019 674 | 1 316 568 | 0,90% | Actions |
| National Philanthropic Trust | $10 006 302 | 1 195 496 | 0,82% | Actions |
| BOOTHBAY FUND MANAGEMENT, LLC | $9 848 828 | 1 176 682 | 0,80% | Actions |
| MILLENNIUM MANAGEMENT LLC | $9 660 888 | 1 154 228 | 0,79% | Actions |
| Caption Management, LLC | $8 370 000 | 1 000 000 | 0,68% | Option de vente |
| Stonepine Capital Management, LLC | $7 950 000 | 650 000 | 0,65% | Option d'achat |
| Public Sector Pension Investment Board | $6 664 370 | 796 221 | 0,54% | Actions |
| ALGERT GLOBAL LLC | $6 505 072 | 777 189 | 0,53% | Actions |
| Stonepine Capital Management, LLC | $6 193 800 | 740 000 | 0,50% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5 749 537 | 686 922 | 0,47% | Actions |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $5 582 790 | 667 000 | 0,45% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $5 461 676 | 652 530 | 0,44% | Actions |
| ARDSLEY ADVISORY PARTNERS LP | $5 022 000 | 600 000 | 0,41% | Actions |
| Y-Intercept (Hong Kong) Ltd | $4 800 873 | 573 581 | 0,39% | Actions |
| JUPITER ASSET MANAGEMENT LTD | $4 755 282 | 568 134 | 0,39% | Actions |
| Caption Management, LLC | $4 603 500 | 550 000 | 0,37% | Option d'achat |
| RHUMBLINE ADVISERS | $4 485 141 | 535 862 | 0,37% | Actions |
| MORGAN STANLEY | $4 475 046 | 534 653 | 0,36% | Actions |
| MARATHON CAPITAL MANAGEMENT | $4 455 795 | 532 353 | 0,36% | Actions |
| JANE STREET GROUP, LLC | $4 363 582 | 521 336 | 0,36% | Actions |
| Caption Management, LLC | $3 933 900 | 470 000 | 0,32% | Actions |
| CITIGROUP INC | $3 932 084 | 469 783 | 0,32% | Actions |
| Swiss National Bank | $3 707 073 | 442 900 | 0,30% | Actions |
| Ruffer LLP | $3 536 005 | 422 958 | 0,29% | Actions |
| AMERIPRISE FINANCIAL INC | $3 495 939 | 417 675 | 0,28% | Actions |
| Point72 Asset Management, L.P. | $3 464 636 | 413 935 | 0,28% | Actions |
| Bridgewater Associates, LP | $3 356 864 | 401 059 | 0,27% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3 303 639 | 394 700 | 0,27% | Option d'achat |
| ASHFORD CAPITAL MANAGEMENT INC | $3 257 115 | 361 500 | 0,27% | Actions |
| FMR LLC | $3 249 586 | 388 242 | 0,26% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3 101 085 | 370 500 | 0,25% | Option de vente |
| Squarepoint Ops LLC | $2 992 300 | 357 503 | 0,24% | Actions |
| Legal & General Group Plc | $2 970 780 | 354 932 | 0,24% | Actions |
| Quantinno Capital Management LP | $2 767 800 | 330 681 | 0,23% | Actions |
| BlackRock, Inc. | $2 716 216 | 324 518 | 0,22% | Actions |
| ALLIANCEBERNSTEIN L.P. | $2 683 926 | 297 883 | 0,22% | Actions |
| Corient Private Wealth LP | $2 667 295 | 318 673 | 0,22% | Actions |
| MARSHALL WACE, LLP | $2 571 717 | 307 254 | 0,21% | Actions |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2 514 907 | 279 124 | 0,20% | Actions |
| Caligan Partners LP | $2 511 000 | 300 000 | 0,20% | Option d'achat |
| STATE OF WISCONSIN INVESTMENT BOARD | $2 370 417 | 283 204 | 0,19% | Actions |
| PFG Investments, LLC | $2 261 390 | 270 178 | 0,18% | Actions |
| Velan Capital Investment Management LP | $2 092 500 | 250 000 | 0,17% | Actions |
| Future Fund LLC | $2 080 146 | 248 524 | 0,17% | Actions |
| H D Vest Advisory Services | $2 024 515 | 111 176 | 0,16% | Actions |
| PRUDENTIAL FINANCIAL INC | $2 007 168 | 239 805 | 0,16% | Actions |
| AMERICAN CENTURY COMPANIES INC | $1 895 961 | 226 518 | 0,15% | Actions |
| Campbell & CO Investment Adviser LLC | $1 875 215 | 224 040 | 0,15% | Actions |
| WOLVERINE TRADING, LLC | $1 821 330 | 123 900 | 0,15% | Option d'achat |
| Rafferty Asset Management, LLC | $1 807 887 | 215 996 | 0,15% | Actions |
| VANGUARD ASSET MANAGEMENT, Ltd | $1 724 379 | 206 019 | 0,14% | Actions |
| DIADEMA PARTNERS LP | $1 674 000 | 200 000 | 0,14% | Option d'achat |
| Mariner, LLC | $1 496 157 | 178 752 | 0,12% | Actions |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $1 357 731 | 74 437 | 0,11% | Actions |
| LPL Financial LLC | $1 336 311 | 159 655 | 0,11% | Actions |
| INTECH INVESTMENT MANAGEMENT LLC | $1 260 355 | 150 580 | 0,10% | Actions |
| WOLVERINE TRADING, LLC | $1 211 280 | 82 400 | 0,10% | Option de vente |
| Virtus Investment Advisers, LLC | $1 185 544 | 141 642 | 0,10% | Actions |
| XTX Topco Ltd | $1 182 756 | 141 309 | 0,10% | Actions |
| UBS Group AG | $1 127 774 | 134 740 | 0,09% | Actions |
| MetLife Investment Management, LLC | $1 125 732 | 134 496 | 0,09% | Actions |
| RAYMOND JAMES FINANCIAL INC | $1 098 563 | 131 250 | 0,09% | Actions |
| Nuveen, LLC | $1 078 901 | 128 901 | 0,09% | Actions |
| Cetera Investment Advisers | $1 073 310 | 128 233 | 0,09% | Actions |
| VANGUARD GROUP INC | $1 065 526 | 58 417 | 0,09% | Actions |
| CreativeOne Wealth, LLC | $1 062 371 | 126 926 | 0,09% | Actions |
| CITADEL ADVISORS LLC | $1 057 131 | 126 300 | 0,09% | Option d'achat |
| Odyssean, LLC | $1 042 048 | 124 498 | 0,08% | Actions |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1 041 086 | 124 383 | 0,08% | Actions |
| CITADEL ADVISORS LLC | $1 037 043 | 123 900 | 0,08% | Option de vente |
| Illinois Municipal Retirement Fund | $988 991 | 118 159 | 0,08% | Actions |
| PROFUND ADVISORS LLC | $988 581 | 118 110 | 0,08% | Actions |
| PERCEPTIVE ADVISORS LLC | $952 213 | 113 765 | 0,08% | Actions |
Initiés de la société 20 initiés · 8 dirigeants · 12 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Adam S Grossman | President and CEO | 16 mars 2026 M | 2 112 777 | 0 | 12 | $-2 082 360 |
| Terry Kohler | CFO and Treasurer | 16 juillet 2026 A | 143 149 | 0 | 0 | $0 |
| Brad L. Tade | CFO and Treasurer | 19 février 2026 F | 232 940 | 0 | 0 | $0 |
| Brian Lenz | EVP, CFO | 7 mars 2024 F | 703 002 | 0 | 0 | $0 |
| Kirk M Warshaw | CFO, Secretary | 13 février 2012 D | 5 208 | 0 | 0 | $0 |
| Arnold P Kling | President | 13 février 2012 D | 8 485 | 0 | 0 | $0 |
| Kaitlin M. Kestenberg-Messina | COO and SVP, Compliance | 24 juillet 2026 F | 443 061 | 0 | 1 | $-157 800 |
| James Mond | EVP, CSO and CMO | 25 février 2021 A | 137 535 | 0 | 0 | $0 |
| Jerrold B Grossman | Administrateur | 27 mai 2026 P | 520 284 | 3 | 0 | $250 874 |
| Lawrence P. Guiheen | Administrateur | 13 mars 2026 M | 30 000 | 0 | 0 | $0 |
| Steve Elms | Administrateur | 6 mars 2026 P | 2 045 730 | 2 | 0 | $217 420 |
| Eduardo Rene Salas | Administrateur | 9 février 2026 A | 21 579 | 0 | 0 | $0 |
| Young Kwon | Administrateur | 9 février 2026 A | 263 020 | 0 | 0 | $0 |
| Alison Cecily Finger | Administrateur | 9 février 2026 A | 45 619 | 0 | 0 | $0 |
| Bryant Fong | Administrateur | 26 février 2024 A | 83 941 | 0 | 0 | $0 |
| Martha J Demski | Administrateur | 6 mars 2023 A | 56 601 | 0 | 0 | $0 |
| Eric I Richman | Administrateur | 28 février 2020 A | 44 030 | 0 | 0 | $0 |
| GOLDSTEIN DOV A MD | Administrateur | 28 février 2020 A | 7 500 | 0 | 0 | $0 |
| Biotest Divestiture Trust | Détenteur de 10% | 6 juin 2019 S | 4 295 580 | 0 | 0 | $0 |
| R & R INVESTMENTS VI LLC | Détenteur de 10% | 13 février 2012 D | 39 340 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 9 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| Caligan Partners LP, David Johnson ×2 dépôts | 9 décembre 2022 | — | Dépôt initial | Investissement passif | SEC |
| The Biotest Divestiture Trust, Eric Rosenbach ×2 dépôts | 7 juin 2019 | — | Dépôt initial | — | SEC |
| Biotest AG ×3 dépôts | 3 août 2018 | — | Dépôt initial | — | SEC |
| Biotest Pharmaceuticals Corporation | 21 mai 2018 | — | Dépôt initial | — | SEC |
| OR ×8 dépôts | 16 novembre 2017 | — | Dépôt initial | — | SEC |
| Biomark Capital Fund IV LP (the “Fund”), Biomark Capital Fund IV GP LLC (the “General Partner”), David S. Wetherell (“Wetherell”) | 30 janvier 2017 | — | Dépôt initial | Investissement passif | SEC |
| Burrill Capital Fund IV, L.P. (the “Fund”), Burrill & Company (BCF IV GP), LLC (the “General Partner”), G. Steven Burrill (“Burrill”), Bryant Fong (“Fong”), Victor Hebert (“Hebert”), Douglas Lind (“Lind”), David Wetherell (“Wetherell”), Joshua Zelig (“Zelig”) ×2 dépôts | 28 octobre 2013 | — | Dépôt initial | Investissement passif | SEC |
| Personne déclarante non divulguée | 15 septembre 2006 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée | 8 septembre 2006 | — | Dépôt initial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 63 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| TMFS · RBB Fund, Inc. | 1,30% | 96 557 NS | 31 mai 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1,16% | 201 155 SH | 8 août 2026 | Quotidien |
| BBP · ETFis Series Trust I | 0,83% | 47 844 NS | 30 avril 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,56% | 281 674 NS | 30 avril 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,32% | 109 641 NS | 31 mai 2026 | N-PORT |
| RZG · Invesco Exchange-Traded Fund Trust | 0,28% | 38 671 SH | 8 août 2026 | Quotidien |
| IJT · iShares Trust | 0,26% | 2 149 439 SH | 8 août 2026 | Quotidien |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,21% | 275 878 SH | 8 août 2026 | Quotidien |
| IBB · iShares Trust | 0,17% | 1 652 272 SH | 8 août 2026 | Quotidien |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,16% | 12 612 SH | 8 août 2026 | Quotidien |
| XJR · iShares Trust | 0,15% | 27 488 SH | 8 août 2026 | Quotidien |
| IWO · iShares Trust | 0,14% | 2 077 912 SH | 8 août 2026 | Quotidien |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,14% | 35 750 SH | 8 août 2026 | Quotidien |
| IJR · iShares Trust | 0,13% | 14 148 426 SH | 8 août 2026 | Quotidien |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,13% | 90 151 NS | 30 avril 2026 | N-PORT |
| BFOR · ALPS ETF Trust | 0,12% | 32 818 NS | 31 mai 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,11% | 247 366 SH | 8 août 2026 | Quotidien |
| BKSE · BNY Mellon ETF Trust | 0,10% | 8 106 NS | 30 avril 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,10% | 807 920 SH | 8 août 2026 | Quotidien |
| BIB · ProShares Trust | 0,10% | 8 805 NS | 31 mai 2026 | N-PORT |
| SAA · ProShares Trust | 0,08% | 2 846 NS | 31 mai 2026 | N-PORT |
| IWM · iShares Trust | 0,07% | 5 870 129 SH | 8 août 2026 | Quotidien |
| ISCG · iShares Trust | 0,07% | 70 846 SH | 8 août 2026 | Quotidien |
| SMDX · Tidal Trust III | 0,07% | 8 104 NS | 30 avril 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,07% | 81 574 NS | 31 mai 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,06% | 1 327 333 SH | 8 août 2026 | Quotidien |
| DFAS · Dimensional ETF Trust | 0,06% | 791 152 NS | 30 avril 2026 | N-PORT |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,05% | 31 008 NS | 30 avril 2026 | N-PORT |
| ITWO · ProShares Trust | 0,05% | 10 910 NS | 31 mai 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,04% | 150 270 NS | 31 mai 2026 | N-PORT |
| EBIT · Harbor ETF Trust | 0,04% | 449 NS | 30 avril 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,04% | 1 140 912 NS | 31 mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,04% | 109 138 NS | 30 avril 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,04% | 77 725 SH | 8 août 2026 | Quotidien |
| ISCB · iShares Trust | 0,04% | 10 075 SH | 8 août 2026 | Quotidien |
| VBK · VANGUARD INDEX FUNDS | 0,03% | 1 448 225 SH | 8 août 2026 | Quotidien |
| VHT · VANGUARD WORLD FUND | 0,03% | 664 197 SH | 8 août 2026 | Quotidien |
| UWM · ProShares Trust | 0,03% | 8 533 NS | 31 mai 2026 | N-PORT |
| WSML · iShares Trust | 0,02% | 14 368 SH | 8 août 2026 | Quotidien |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 2 659 600 SH | 8 août 2026 | Quotidien |
| URTY · ProShares Trust | 0,02% | 8 634 NS | 31 mai 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 31 610 SH | 8 août 2026 | Quotidien |
| VB · VANGUARD INDEX FUNDS | 0,01% | 2 517 984 SH | 8 août 2026 | Quotidien |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,01% | 128 NS | 31 mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 9 059 NS | 31 mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 217 NS | 31 mai 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 63 237 NS | 31 mai 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 7 854 NS | 30 avril 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 151 191 NS | 30 avril 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 37 593 NS | 30 avril 2026 | N-PORT |